ESIFLO 250 TRANSCAP is a potent combination of Fluticasone and Salmeterol that belongs to the Corticosteroids and Bronchodilators group respectively. This medication is specifically designed to address respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Asthma is a chronic respiratory ailment characterized by inflamed and constricted airways, accompanied by excessive mucus production, resulting in symptoms like wheezing, breathing difficulties, chest pain, and cough. On the other hand, COPD is a lung disease marked by persistent lung inflammation and obstructed airflow in the airways, leading to symptoms like wheezing, cough with mucus, and chest discomfort.

ESIFLO 250 TRANSCAP should be used consistently as advised by your healthcare provider, typically through inhalation and not by swallowing the medicine. It is crucial to maintain regular usage of this medication even if symptoms improve, as abruptly discontinuing it without medical consultation can have adverse effects on conditions like asthma and COPD. This drug is suitable for adults and adolescents aged 12 years and above, but it should not be utilized during sudden asthma attacks. In such emergencies, it is recommended to seek medical attention or use a fast-acting reliever inhaler containing salbutamol to alleviate symptoms promptly.

Prior to initiating the use of ESIFLO 250 TRANSCAP, it is imperative to inform your doctor about any existing lung infections, liver issues, or heart conditions. Additionally, disclosing any history of diabetes, hypertension, seizures, hyperthyroidism, osteoporosis, adrenal gland problems, or compromised immune function is advisable for precautionary measures. Pregnant or breastfeeding individuals should only use this medication if prescribed by a healthcare professional, considering the potential benefits and risks involved.

The most common side effects associated with ESIFLO 250 TRANSCAP include headaches, cold symptoms, oral fungal infections or sores, throat irritation, hoarseness of voice, muscle aches, and joint pain. In case any of these side effects escalate or persist, it is essential to consult your doctor promptly for appropriate guidance and possible adjustments to the treatment plan. Through proper and consistent use, ESIFLO 250 TRANSCAP effectively aids in managing and preventing respiratory issues, contributing to improved breathing and overall quality of life.

Esiflo 250 Transcaps offers several benefits for individuals dealing with respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. This medication works by helping to keep the airways in the lungs open, making it easier for air to flow in and out. By relaxing the muscles in the airways, Esiflo 250 Transcaps can provide relief from symptoms like chest tightness, shortness of breath, wheezing, and coughing. Using this medication can significantly enhance daily activities by making it easier to breathe.

For individuals with asthma, Esiflo 250 Transcaps can be particularly beneficial in preventing asthma attacks, especially if taken before activities like exercise or exposure to triggers such as house dust, pollen, pets, or cigarette smoke. By taking this medication, individuals can exercise more freely without worrying about experiencing symptoms like wheezing, coughing, and shortness of breath. This freedom allows individuals to live their lives more fully without the constant concern of triggering their asthma symptoms.

Esiflo 250 Transcaps, containing a combination of Salmeterol and Fluticasone, effectively treats and prevents respiratory disorders like asthma attacks and COPD. Salmeterol acts as a bronchodilator, relaxing the airway muscles and increasing airflow to the lungs. This action widens the airways and makes breathing easier. On the other hand, Fluticasone, a corticosteroid, functions by blocking the production of prostaglandins, chemical messengers that cause inflammation in the airways. Additionally, Fluticasone exhibits potent vasoconstrictive and anti-inflammatory properties, further aiding in the management of respiratory conditions.

Overall, Esiflo 250 Transcaps is a safe and effective medication that can provide quick relief within a few minutes and last for several hours. It is essential to follow your doctor's advice and not discontinue its use without consulting them to ensure optimal management of respiratory symptoms and improved quality of life.

To use Esiflo 250 Transcaps, first, remember that the Transcaps should not be swallowed. Always check the label for directions before use. Place the Transcap at the base of the transhaler, not in the mouthpiece. Twist the mouthpiece completely until you hear a click sound, then breathe in deeply through the mouthpiece. Hold your breath for up to 10 seconds. If there is any powder left in the transhaler, repeat the process.

When using the inhaler, hold it with the mouthpiece facing downwards. Create a tight seal by putting your lips around the mouthpiece. Breathe in slowly through your mouth and press down on the inhaler once. Remove the inhaler and breathe normally.

Esiflo 250 Transcaps contain powdered medication that is meant for inhalation only. The Transcap is a capsule that is placed in a device called a Rotahaler or Transhaler. The Rotahaler/Transhaler is a plastic inhalation device that releases the medication when you breathe in. Remember not to swallow the capsule. Place it at the base of the Rotahaler/Transhaler, twist the mouthpiece until you hear a click sound, then breathe in deeply through the mouthpiece and hold your breath for 10 seconds.

Remember to read the instruction leaflet before using the medication and use it in the dose and duration recommended by your doctor. Do not stop using Esiflo 250 Transcaps without consulting your doctor, even if your symptoms improve.

Always follow the instruction given in the enclosed leaflet and consult your doctor to determine the correct dose and duration based on your age, body weight, and disease condition. Do not start using this medication unless your doctor or healthcare provider has provided proper instruction on how to use it correctly.

Esiflo 250 Transcaps are primarily used for treating Chronic obstructive pulmonary disease (COPD) and Asthma. These conditions include Chronic Obstructive Pulmonary Disease (COPD), Bronchitis, Asthma, and Emphysema. This medication is effective in managing symptoms related to these respiratory conditions, helping patients breathe better and improve their overall quality of life. Esiflo 250 Transcaps plays a crucial role in the treatment of COPD and Asthma, providing relief to individuals suffering from these chronic respiratory issues.

Esiflo 250 Transcaps is commonly used to manage asthma, a chronic respiratory condition where the airways narrow, swell, and produce excess mucus, leading to breathing difficulties. Symptoms include wheezing, shortness of breath, chest tightness, and cough, especially at night. Asthma can range from mild persistent, occurring more than twice a week, to severe persistent, happening multiple times daily. Treatment involves medication, breathing exercises, and self-care to control symptoms and improve lung function. Additionally, the medication may also be prescribed for COPD, characterized by emphysema and chronic bronchitis, usually caused by smoking and prolonged exposure to harmful substances, showing symptoms like chronic cough and wheezing.

It is important to seek medical help if you are experiencing respiratory failure, acute asthma attacks, or if you have any of the following conditions: over-active thyroid gland, diabetes, high blood pressure, hypokalemia, seizures, osteoporosis, weak immune system, eye problems, viral/bacterial/fungal infections, glucose intolerance, adrenal gland issues, or have recently experienced a major trauma or surgery. If you have any of these conditions or symptoms, it is advisable to inform your physician before using Esiflo 250 Transcaps to ensure its safe use and effectiveness for your specific health needs. Seeking medical advice in these situations is crucial to prevent any adverse reactions or complications that may arise from using this medication.

When taking Esiflo 250 Transcaps, some individuals may experience side effects as their body adjusts to the medication. It's important to note that most side effects are mild and do not require immediate medical attention. These can include coughing, upper respiratory tract infections, nasal inflammation, sinus issues, stomach discomfort, fungal infections in the mouth and throat, changes in voice, headaches, and dry mouth. Other potential side effects may involve nausea, vomiting, respiratory infections, sore throat, bone or muscle pain, increased heart rate, chills, black stools, and noisy breathing.

In some cases, more severe side effects may occur, such as elevated blood sugar levels, cloudy eyes (cataracts), rapid or irregular heartbeat, chest pain, sleep disturbances, allergic skin reactions, thrush in the mouth or throat, muscular or joint pain, joint swelling, easy bruising, and fractures. Additionally, issues like sinus inflammation, low potassium levels, reduced growth in adolescents, bone weakening, glaucoma, weight gain, Cushing’s Syndrome, changes in behavior like hyperactivity and irritability, and fungal infections in the esophagus that cause swallowing difficulties may arise.

If any of the following serious side effects occur, immediate medical attention is necessary: severe allergic reactions manifesting as wheezing, coughing, shortness of breath, skin rash, swelling of the face or throat, rapid heartbeat leading to fainting, dizziness, or loss of consciousness, as well as signs of pneumonia such as fever, increased cough, breathing difficulties, and changes in mucus color. It is crucial to cease using Esiflo 250 Transcaps and contact a healthcare provider promptly if any of these severe side effects are experienced.

Esiflo 250 Transcaps should be taken with caution in elderly patients (aged 65 years or above). Therefore, consult your doctor before using it. Proper dose adjustments and careful monitoring are required in such patients.

Esiflo 250 Transcaps is not recommended for use in children younger than 12 years of age. Kindly consult your doctor before using it.

Before taking Esiflo 250 Transcaps it is crucial to heed certain warnings for your safety. Firstly, do not halt the medication unless advised by your doctor. Notify your medical provider if you have a history of heart, liver, kidney problems, high cortisol levels, eye issues like cataracts or glaucoma, seizures, weak bones, or diabetes. This medicine may lower potassium levels, hence caution is advised in patients with low potassium to avoid cardiovascular complications. Individuals with infections or tuberculosis need extra care due to the risk of secondary infections from corticosteroids like Fluticasone in Esiflo 250 Transcaps. Diabetics should closely monitor their blood sugar levels as the medication can elevate glucose levels. Inform your doctor if you are pregnant, planning a pregnancy, or breastfeeding. If you face drowsiness or irregular heartbeats, refrain from driving or using machinery. Lastly, it is advisable to avoid alcohol consumption while on this medication to prevent exacerbation of side effects.

If you forget to take a dose of Esiflo 250 Transcaps, try to take it as soon as you remember. But if it's almost time for your next scheduled dose, then skip the missed dose and continue with your usual dosing routine. It's important not to take a double dose to make up for the missed one. Just resume your medication at the next scheduled time to stay on track with your treatment plan.

If too much Esiflo 250 Transcaps is accidentally inhaled, it is crucial to seek medical help promptly. Overdosing on this medication can lead to various symptoms, such as shortness of breath, chest pain, rapid heartbeat, shakiness, dizziness, headaches, muscle weakness, and joint pain. If any of these signs occur, it is important to contact a doctor or go to the hospital immediately for evaluation and treatment.

When taking Esiflo 250 Transcaps, your healthcare provider may recommend certain lab tests to monitor your health and the effectiveness of the medication. Two important lab tests to consider are the Absolute Eosinophil Count and the Complete Blood Count.

The Absolute Eosinophil Count measures the number of eosinophils, a type of white blood cell, in your blood. Eosinophils play a role in the immune system and their count may increase in response to allergies or certain conditions. Monitoring the Absolute Eosinophil Count can help track inflammation and the body's response to treatments like Esiflo 250 Transcaps.

The Complete Blood Count (CBC) provides important information about various blood components, such as red blood cells, white blood cells, and platelets. It can help detect infections, anemia, or other abnormalities that may affect your overall health. Regular CBC tests can help your healthcare provider assess how your body is responding to Esiflo 250 Transcaps and make any necessary adjustments to your treatment plan.

In summary, the Absolute Eosinophil Count and Complete Blood Count are essential lab tests that may be recommended while taking Esiflo 250 Transcaps. These tests can provide valuable information about your health status and the medication's impact on your body.